Wegovy BMI Results UK: Clinical Trial Data | Cured

Clinically Proven UK Registered Pharmacy

Cheapest Wegovy BMI Results - UK Price From £69.00

Get Wegovy at the cheapest UK price from £69.00 with £20 off your first order using code WEIGHTLOSSNEW.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off first order using code WEIGHTLOSSNEW

Treatment from £69.00

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Real Wegovy BMI Results: Clinical Evidence from UK

Published on: June 03, 2026

Searching for reliable wegovy bmi results uk data? Clinical trials demonstrate that Wegovy (semaglutide 2.4mg) can help patients achieve an average BMI reduction of 5-6 points over 68 weeks, with some participants losing up to 17.4% of their starting body weight [1]. At Cured Pharmacy, our UK-registered clinical team prescribes genuine Wegovy from £79.00, following a free online consultation that takes under three minutes.

What the STEP Clinical Trials Tell Us About Wegovy BMI Results UK

The STEP (Semaglutide Treatment Effect in People with Obesity) programme represents the largest body of evidence for Wegovy's effectiveness in the UK and globally [1]. Across five major trials involving over 4,500 participants, researchers measured BMI changes, waist circumference reduction, and cardiometabolic improvements in adults with obesity or overweight with weight-related comorbidities.

In STEP 1—the pivotal trial that informed MHRA licensing—participants using Wegovy 2.4mg weekly achieved an average weight loss of 14.9% compared to 2.4% with placebo over 68 weeks [1]. For a patient starting at BMI 38 (approximately 108kg at 170cm height), this translates to a BMI reduction of approximately 5.7 points, bringing them down to a BMI of 32.3. Importantly, 86.4% of Wegovy-treated participants achieved at least 5% weight loss, and 69.1% lost 10% or more [1].

STEP 5 extended the observation period to 104 weeks, demonstrating sustained BMI reduction with an average weight loss of 15.2% maintained beyond two years [2]. This long-term data addresses a critical question many UK patients ask: whether Wegovy results plateau or reverse after the first year. The evidence shows continued benefit when treatment is maintained alongside lifestyle modifications.

How Wegovy Works to Reduce BMI

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural gut hormone involved in appetite regulation and glucose metabolism [3]. Unlike older weight loss medications that work peripherally, semaglutide acts on receptors in the brain's appetite centres, reducing hunger signals and increasing feelings of fullness after smaller meals.

The medication also slows gastric emptying, meaning food stays in your stomach longer, which contributes to prolonged satiety between meals [3]. This dual mechanism—central appetite suppression and delayed gastric transit—explains why clinical trial participants reported finding it easier to adhere to reduced-calorie diets without the intense hunger that often derails weight loss efforts.

Wegovy is administered as a once-weekly subcutaneous injection, starting at 0.25mg and gradually escalating to the maintenance dose of 2.4mg over 16-20 weeks. This dose escalation schedule, developed through clinical trials, minimises gastrointestinal side effects whilst allowing your body to adapt to the medication's effects [1].

Who Qualifies for Wegovy in the UK

Under MHRA licensing and NICE guidance, Wegovy is indicated for adults with a BMI of 30 kg/m² or greater, or a BMI of 27 kg/m² or greater with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [4]. UK prescribers assess your medical history, current medications, and weight loss goals during the clinical consultation to determine suitability. All prescriptions at Cured Pharmacy are issued following assessment by a UK-registered prescriber, in full compliance with GPhC regulations.

Wegovy BMI Results UK: What to Expect in Your First 6 Months

Most patients begin noticing weight changes within the first 4-8 weeks of starting Wegovy, though initial results during the dose escalation phase are modest [1]. During weeks 1-4 at the 0.25mg starting dose, you may lose 1-2kg as your appetite begins to regulate. This is intentional—the gradual escalation allows your body to adapt whilst minimising nausea and other gastrointestinal effects.

By week 20, when you reach the full 2.4mg maintenance dose, clinical trial data shows patients had achieved approximately 10-12% of their total weight loss [1]. For someone starting at BMI 35, this represents a BMI reduction of roughly 3.5-4 points. The most significant weight loss typically occurs between weeks 20 and 60, as you maintain the therapeutic dose alongside dietary and activity modifications.

Individual results vary considerably based on adherence, baseline metabolic health, and lifestyle factors. In our experience at Cured Pharmacy, patients who combine Wegovy with structured nutritional support and regular physical activity tend to achieve results closer to the upper range reported in clinical trials. Your UK prescriber will monitor your progress and may adjust your treatment plan if you're not achieving at least 5% weight loss by week 16 on the maintenance dose, in line with NICE guidance [4].

Managing Side Effects During Treatment

The most commonly reported side effects in STEP trials were gastrointestinal: nausea (44%), diarrhoea (30%), vomiting (24%), and constipation (24%) [1]. These effects are typically mild to moderate, occur most frequently during dose escalation, and diminish over time as your body adapts. Eating smaller, more frequent meals and avoiding high-fat foods can help manage these symptoms. If side effects persist or become severe, your prescriber may slow the dose escalation or pause treatment temporarily.

Treatment Active Ingredient Average Weight Loss Dosing Frequency Starting Price
Wegovy Semaglutide 2.4mg 15-17% over 68 weeks Once weekly injection From £69.00
Saxenda Liraglutide 3mg 8% over 56 weeks Daily injection From £68.00
Orlistat Orlistat 120mg 3-5% over 12 months Three times daily oral From £32.00
Mysimba Naltrexone/Bupropion 5-6% over 56 weeks Twice daily oral From £125.95

Comparing Wegovy BMI Results to Other UK Weight Loss Treatments

When UK patients research weight loss medications, they often compare Wegovy to other licensed options. Orlistat, available over the counter for BMI ≥28, works by blocking fat absorption in the gut and produces an average weight loss of 3-5% over 12 months—significantly less than Wegovy's 15-17% [5]. Orlistat also requires strict dietary fat restriction to avoid unpleasant gastrointestinal effects.

Saxenda (liraglutide 3mg) is another GLP-1 receptor agonist, but requires daily injections rather than weekly dosing. Clinical trials of Saxenda showed average weight loss of 8% over 56 weeks—effective, but roughly half the magnitude seen with Wegovy [6]. The daily injection schedule can also affect long-term adherence for some patients.

Mounjaro (tirzepatide), a newer dual GIP/GLP-1 receptor agonist, has shown even greater weight loss in trials—up to 22.5% in the SURMOUNT programme [7]. However, Mounjaro is currently licensed in the UK primarily for type 2 diabetes, with weight management licensing expected. Your UK prescriber will help you understand which medication aligns best with your medical profile, preferences, and treatment goals.

Long-Term BMI Maintenance After Wegovy Treatment

A critical question for anyone considering Wegovy is what happens when treatment stops. The STEP 4 trial specifically examined this by randomising participants who had been on Wegovy for 20 weeks to either continue treatment or switch to placebo [2]. Those who discontinued Wegovy regained approximately two-thirds of their lost weight over the subsequent 48 weeks, whilst those who continued maintained their weight loss.

This data suggests that Wegovy is most effective as a long-term treatment rather than a short-term intervention. The MHRA has licensed it for chronic weight management, recognising that obesity is a chronic relapsing condition requiring ongoing treatment, much like hypertension or type 2 diabetes [4]. Many patients at Cured Pharmacy continue treatment for 12-24 months or longer, with regular prescriber reviews every three months to assess ongoing benefit and tolerability.

Behavioural changes established during treatment—such as portion control, mindful eating, and regular physical activity—become crucial for maintaining results if you eventually discontinue Wegovy. Working with a dietitian or weight management service alongside pharmacological treatment can help embed these sustainable habits.

When to Consider Stopping Treatment

NICE guidance recommends discontinuing Wegovy if you haven't achieved at least 5% weight loss after 6 months on the maintenance dose, as you're unlikely to achieve clinically meaningful benefit with continued treatment [4]. Your prescriber will also reassess treatment if you experience persistent side effects, develop contraindications, or reach your target weight and wish to attempt maintenance through lifestyle measures alone. Any decision to stop should be made collaboratively with your UK healthcare provider, with a plan for ongoing weight monitoring.

How to Start Wegovy Treatment at Cured Pharmacy

Starting your Wegovy treatment journey at Cured Pharmacy begins with a free online consultation that takes under three minutes to complete. You'll answer questions about your current weight, height, medical history, existing medications, and weight loss goals. This information is reviewed by our UK-registered prescribers, led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), who will assess your suitability for treatment.

If Wegovy is deemed appropriate and safe for you, your prescription is issued electronically and dispensed from our GPhC-registered pharmacy (9012511). We supply only genuine UK-licensed Wegovy pens, delivered in discreet packaging directly to your address. Your first prescription will include the 0.25mg starting dose pens along with clear instructions for dose escalation and injection technique.

Wegovy is priced from £79.00 at Cured Pharmacy, with transparent pricing shown before you complete your consultation—no hidden fees or surprise charges. We offer the lowest prices guaranteed in the UK for genuine licensed medicines. Follow-up prescriptions can be ordered through your patient account, with ongoing prescriber reviews to monitor your progress and adjust treatment as needed. You can contact our clinical team on (+44) 116 4646009 if you have questions during your treatment.

Scientific References

  1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  2. Garvey, W. T., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4 [accessed 13 August 2026]
  3. Nauck, M. A., et al. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. https://doi.org/10.1016/j.molmet.2020.101102 [accessed 13 August 2026]
  4. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
  5. Torgerson, J. S., et al. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
  6. Pi-Sunyer, X., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
  7. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  8. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  9. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  10. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence, lifestyle modifications, and baseline health status.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

What BMI do you need for Wegovy in the UK?
Wegovy is licensed in the UK for adults with a BMI of 30 kg/m² or above, or BMI 27 kg/m² or above with at least one weight-related health condition such as type 2 diabetes, hypertension, or sleep apnoea. Your UK prescriber will assess your eligibility during the clinical consultation.
How much weight can you lose on Wegovy in 3 months?
During the first 12 weeks, you'll still be in the dose escalation phase, gradually increasing from 0.25mg to 1.7mg. Clinical trial participants typically lost 5-7% of their body weight by month 3, though individual results vary based on starting weight, adherence, and lifestyle factors.
Will my BMI results with Wegovy match the clinical trial data?
Individual results vary considerably. Whilst STEP trials showed average weight loss of 15-17%, some participants lost significantly more and others less. Factors affecting your results include baseline metabolic health, medication adherence, dietary habits, physical activity levels, and genetic factors influencing weight regulation.
Do Wegovy BMI results plateau after the first year?
STEP 5 trial data shows that weight loss continues through 104 weeks, with participants maintaining an average 15.2% reduction at the two-year mark. Most weight loss occurs in the first 60-68 weeks, after which results typically stabilise rather than plateau, provided treatment continues.
Can I get Wegovy on the NHS in the UK?
Wegovy is approved by NICE for NHS use in specialist weight management services, but availability is extremely limited due to supply constraints and commissioning decisions. Most UK patients access Wegovy through private prescriptions from registered online pharmacies like Cured Pharmacy, where it's available from £79.00 following clinical assessment.
What happens to my BMI if I stop taking Wegovy?
STEP 4 trial data shows that participants who discontinued Wegovy after 20 weeks regained approximately two-thirds of their lost weight over the following 48 weeks. Wegovy is designed for long-term use, and maintaining results after stopping requires sustained lifestyle modifications established during treatment.
How do Wegovy BMI results compare to Mounjaro?
Head-to-head trials show tirzepatide (Mounjaro) produces greater average weight loss—up to 22.5% versus Wegovy's 15-17%. However, Mounjaro is currently licensed in the UK primarily for type 2 diabetes, whilst Wegovy has full weight management licensing. Your prescriber will assess which medication suits your clinical profile.
Is Wegovy safe for long-term use in the UK?
Wegovy has been studied for up to 104 weeks in clinical trials with an acceptable safety profile. The MHRA has licensed it for chronic weight management, recognising obesity as a long-term condition. Your UK prescriber will conduct regular reviews every 3 months to monitor ongoing safety, efficacy, and any emerging side effects.
What BMI do I need to qualify for Wegovy in the UK?
To qualify for Wegovy in the UK, you typically need a BMI of 30 or above, or a BMI of 27 or above with a weight-related health condition such as type 2 diabetes or high blood pressure. Cured Pharmacy's UK-registered prescribers will assess your eligibility during the online consultation to ensure Wegovy is safe and appropriate for you.
How much BMI reduction can I expect with Wegovy?
Clinical trials show that Wegovy users typically lose 10-15% of their body weight over 68 weeks, which can translate to a significant BMI reduction depending on your starting weight. Cured Pharmacy provides ongoing support throughout your Wegovy treatment to help you achieve the best possible BMI results with lifestyle changes alongside medication.
Can I track my Wegovy BMI results through Cured Pharmacy?
Yes, Cured Pharmacy encourages regular weight and BMI tracking throughout your Wegovy treatment to monitor your progress effectively. During follow-up consultations, our prescribers review your BMI results and can adjust your treatment plan to ensure you continue achieving safe and sustainable weight loss outcomes.
Is Wegovy more effective for higher BMI patients in the UK?
Wegovy has been proven effective across a range of BMI levels, though patients with higher starting BMIs may see greater absolute weight loss in kilograms. However, percentage body weight reduction tends to be consistent regardless of starting BMI. Cured Pharmacy's prescribers tailor treatment plans based on your individual BMI and health goals to maximise your results.
How quickly will I see BMI changes after starting Wegovy?
Most patients begin to see measurable BMI reduction within 4-8 weeks of starting Wegovy, with more significant results appearing after 12-16 weeks as you reach higher maintenance doses. Cured Pharmacy recommends monthly BMI checks to track your progress and ensure you're responding well to treatment throughout your weight loss journey.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.